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General procedure: 
All olefin oxidation reactions were carried out under aerobic conditions. Commercial 
reagents were obtained from Aldrich and used without further purification.  
     
1
H and 
13
C NMR spectra were recorded on a Varian 500 Mhz spectrometer and High 
resolution mass spectra were provided by the California Institute of Technology Mass 
Spectrometry Facility using JEOL JMS-600H High Resolution Mass Spectrometer. 
Substrates in Table 1, Entries 1 and 4 were prepared by standard benzylation using NaH and 
BnBr in THF. Substrates in Table 1, Entries 2 and 5, as well as substrates in Scheme 5, were 
prepared by treatment of the corresponding alcohol with the corresponding benzoyl chloride 
in CH2Cl2 with 1.5 eq. pyridine. Catalyst 1 and 2 are commercially available from Sigma-
Aldrich. 
General Procedure 1 for Wacker-oxidation of alkenes (Table 1, Scheme 2, 3, 4 and 5): 
Palladium acetate (11.5 mg, 0.05 mmol, 5 mol%) and benzoquinone (108 mg, 1.00 mmol) 
were charged in a resealable 20-mL vial under air. A mixture of MeCN (4.5 mL) and water 
(0.63 mL) was added, followed by the addition of aqueous HBF4 (0.18 mL, 48% in water, 
1.38 mmol). After the addition of the corresponding substrate (1.00 mmol), the homogenous 
reaction mixture was stirred for 16 h at room temperature. The crude reaction mixture was 
then diluted with brine (30 mL) and extracted with CH2Cl2 (3x30 mL). The combined organic 
phases were then dried over Na2SO4, filtered, and evaporated in vacuo. NMR-analysis of the 
crude mixture was performed to determine the regioselectivity of the process. The crude 
product was then further purified by column chromatography on silica gel using 
pentane/ether as eluent. 
General Procedure 2 for cross-metathesis reactions using catalyst 1 (Scheme 2 and 4): 
The corresponding limiting alkene substrate (1 mmol, 1 equiv.) and the excess cross-partner 
(5.00 mmol, 5 equiv.) were charged in a resealable 20-mL vial in a nitrogen filled drybox. 
Dry CH2Cl2 (2.5 mL) was added, followed by the addition of Grubbs-Hoveyda second 
generation catalyst (31.3 mg, 0.05 mmol, 5 mol%). The vial was sealed and taken out of the 
glove-box, put under an Argon atmosphere (balloon) and was stirred for 20 h at 40°C before 
being quenched by addition of ethyl vinyl ether (few drops). The solvent was then evaporated 
and the E/Z ratio was determined by NMR-analysis of the crude reaction mixture. The crude 
product was then further purified by column chromatography on silica gel using 
pentane/ether as eluent. 
General Procedure 3 for Z-selective cross-metathesis reactions using catalyst 2 (Scheme 
3): The corresponding limiting alkene substrate (0.4 mmol) was weighted out in a 4-mL 
scintillation vial in a nitrogen-filled glove-box. Distilled decene (0.4 mL, 2.1 mmol, 5 equiv) 
was added, followed by addition of a stock solution of catalyst 2 in THF (0.01 M, 0.8 mL, 
0.008 mmol, 2 mol%). The mixture was then stirred open in the glove box for 10 h at the 
indicated temperature, and was then taken out of the box and quenched by addition of ethyl 
vinyl ether (few drops). The solvent was evaporated and the E/Z ratio was determined by 
NMR-analysis of the crude reaction mixture. The crude product was then further purified by 
column chromatography on silica gel using pentane/ether as eluent. 
 
 1-(benzyloxy)octan-3-one (Table 1, Entry 1) 
 Was obtained in 71% yield (100 mg, 0.43 mmol) following general procedure 1 on a 0.6 
mmol scale. 
1
H NMR (500 MHz, Chloroform-d): δ 7.42–7.19 (m, 5H), 4.51 (s, 2H), 3.74 (t, J = 6.3 Hz, 
2H), 2.69 (t, J = 6.3 Hz, 2H), 2.43 (t, J = 7.4 Hz, 2H), 1.58 (p, J = 7.2 Hz, 2H), 1.39 – 1.18 
(m, 4H), 0.88 (t, J = 7.0 Hz, 3H). 
Values are in accordance with literature.
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3-oxooctyl benzoate (Table 1, Entry 2) 
 
Was obtained in 80% yield (199 mg, 0.80 mmol) following general procedure 1 on a 1 mmol 
scale. 
1
H NMR (500 MHz, Chloroform-d):  δ 8.03–7.96 (m, 2H), 7.58–7.52 (m, 1H), 7.43 (t, J = 
8.1 Hz, 2H), 4.59 (t, J = 6.4 Hz, 2H), 2.87 (t, J = 6.4 Hz, 2H), 2.47 (t, J = 7.4 Hz, 2H), 1.61 
(p, J = 7.5 Hz, 2H), 1.35 – 1.21 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H). 
13
C NMR (125 MHz, Chloroform-d): δ 208.1, 166.4, 133.0, 123.0, 129.6, 128.3, 60.0, 43.3, 
41.4, 31.3, 23.3, 22.4, 13.9. 
 
HRMS (EI): calcd for C15H21O3 (M
+
 + H): 249.1491; found 249.1484. 
 
4-oxopentan-2-yl benzoate (Table 1, Entry 3) 
                                                             
1 Tetrahedon. Lett 52, 2950. 
 Was obtained in 80% yield (164 mg, 0.80 mmol) following general procedure 1 on a 1 mmol 
scale. 
1
H NMR (500 MHz, Chloroform-d): δ 7.99 (dd, J = 8.4, 1.3 Hz, 2H), 7.56–7.50 (m, 1H), 
7.44–7.39 (m, 2H), 5.53 (h, J = 6.3 Hz, 1H), 2.95 (dd, J = 16.3, 6.9 Hz, 1H), 2.69 (dd, J = 
16.3, 6.0 Hz, 1H), 2.18 (s, 3H), 1.40 (d, J = 6.3 Hz, 3H). 
Values are in accordance with literature.
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6-(benzyloxy)hexan-3-one (Table 1, Entry 4) 
 
Was obtained in 80% yield (33 mg, 0.16 mmol, 9:1 mixture of regioisomers) following 
general procedure 1 on a 0.2 mmol scale. The isomers ratio was 6.5:1 in the crude reaction 
mixture as determined by 
1
H-NMR. 
1
H NMR (500 MHz, Chloroform-d, major): δ 7.31 (m, 5H), 4.48 (s, 2H), 3.48 (t, J = 6.1 Hz, 
2H), 2.52 (t, J = 7.2 Hz, 2H), 2.42 (q, J = 7.3 Hz, 2H), 1.90 (p, J = 6.7 Hz, 2H), 1.04 (t, J = 
7.3 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 211.4, 138.4, 128.4, 127.6, 127.6, 72.8, 69.4, 
38.9, 36.0, 23.9, 7.8 
 
HRMS (FAB): calcd for C13H19O2 (M
+
 + H): 207.1385; found 207.1387. 
 
4-oxohexyl benzoate (Table 1, Entry 5) 
 
                                                             
2 Tetrahedron Lett. 49, 3326. 
Was obtained in 83% yield (110 mg, 0.50 mmol, 10:1 mixture of regioisomers) following 
general procedure 1 on a 0.6 mmol scale. 
1
H NMR (500 MHz, Chloroform-d): δ 8.03 (d, J = 3.0 Hz, 2H), 7.59–7.54 (m, 1H), 7.48–7.42 
(m, 2H), 4.33 (t, J = 6.4 Hz, 2H), 2.58 (t, J = 7.2 Hz, 2H), 2.45 (q, J = 7.3 Hz, 2H), 2.12–2.02 
(m, 2H), 1.06 (t, J = 7.3 Hz, 3H). 
 
Values are in accordance with literature.
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methyl 4-oxopentanoate (Table 1, Entry 6) 
 
Was obtained in 70% yield (91 mg, 0.7 mmol) following general procedure 1 on a 1 mmol 
scale. 
1
H NMR (500 MHz, Chloroform-d): δ 3.64 (s, 3H), 2.73 (t, J = 6.6 Hz, 2H), 2.54 (t, J = 6.6 
Hz, 2H), 2.16 (s, 3H). 
 
Values are in accordance with literature.
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4-methyl-N-(3-oxobutyl)benzenesulfonamide (Table 1, Entry 7) 
 
Was obtained in 72% yield (173 mg, 0.72 mmol) following general procedure 1 on a 1 mmol 
scale. 
                                                             
3 Org. Lett. 13, 4308. 
4 Org. Lett. 13, 3856. 
1
H NMR (500 MHz, Chloroform-d): δ 7.72 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.6 Hz, 2H), 5.22 
(t, J = 6.5 Hz, 1H), 3.14 – 3.08 (m, 2H), 2.67 (t, J = 5.8 Hz, 2H), 2.41 (s, 3H), 2.09 (s, 3H). 
 
Values are in accordance with literature.
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methyl tridec-2-enyl carbonate (Scheme 2) 
 
Was obtained in 68% yield (350 mg, 1.37 mmol, 10:1 E/Z) following general procedure 2 on 
a 2 mmol scale using dodecene as the limiting alkene and allyl carbonate as the cross-partner 
(4 equiv). 
1
H NMR (500 MHz, Chloroform-d, major): δ 5.85–5.76 (m, 1H), 5.62–5.53 (m, 1H), 4.61–
4.52 (m, 2H), 3.78 (s, 3H), 2.05 (q, J = 7.0 Hz, 2H), 1.36 (m, 2H), 1.29 (m, 14H), 0.88 (t, J = 
7.0 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 155.7, 137.6, 123.0, 68.7, 54.7, 32.2, 31.9, 
29.6, 29.6, 29.4, 29.3, 29.1, 28.8, 22.7, 14.1. 
 
HRMS (EI): calcd for C15H28O3 (M
+
): 256.2038; found 256.2035. 
 
 
methyl 3-oxotridecyl carbonate (Scheme 2) 
 
Was obtained in 80% yield (65 mg, 0.24 mmol) following general procedure 1 on a 0.3 mmol 
scale. 
                                                             
5 Tetrahedron 53, 8887. 
1
H NMR (500 MHz, Chloroform-d): δ 4.39 (t, J = 6.3 Hz, 2H), 3.77 (s, 3H), 2.77 (t, J = 6.3 
Hz, 2H), 2.47–2.37 (m, 2H), 1.64–1.49 (m, 2H), 1.25 (d, J = 7.2 Hz, 14H), 0.87 (t, J = 7.0 
Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d): δ 207.6, 155.5, 62.8, 54.8, 43.3, 41.2, 31.9, 29.5, 29.4, 
29.4, 29.3, 29.1, 23.5, 22.7, 14.1. 
 
HRMS (EI): calcd for C15H29O4 (M+H
+
): 273.2066; found 273.2067. 
 
 
2-(hept-2-enyl)isoindoline-1,3-dione (Scheme 2) 
 
Was obtained in 70% yield (170 mg, 0.70 mmol, 7:1 E/Z) following general procedure 2 on a 
1 mmol scale using allyl phthalimide as the limiting reagent and hexene as the cross-partner 
(5 equiv). 
1
H NMR (500 MHz, Chloroform-d, major): δ 7.84 (dd, J = 5.4, 3.0 Hz, 2H), 7.70 (dd, J = 5.5, 
3.0 Hz, 2H), 5.79–5.69 (m, 1H), 5.55–5.43 (m, 1H), 4.23 (dq, J = 6.3, 1.0 Hz, 2H), 2.00 (q, J 
= 7.8 Hz, 2H), 1.43–1.18 (m, 4H), 0.86 (t, J = 7.2 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 168.0, 135.3, 133.8, 132.2, 123.2, 123.0, 39.6, 
31.8, 31.0, 22.2, 13.9. 
 
HRMS (EI): calcd for C15H17O2N (M
 +
): 243.1259; found 243.1265. 
 
2-(3-oxoheptyl)isoindoline-1,3-dione (Scheme 2) 
 
Was obtained in 77% yield (40 mg, 0.15 mmol) following general procedure 1 on a 0.2 mmol 
scale. 
1
H NMR (500 MHz, Chloroform-d): δ 7.83 (dd, J = 5.4, 3.0 Hz, 2H), 7.70 (dd, J = 5.5, 3.0 
Hz, 2H), 3.99–3.89 (m, 2H), 2.84 (dd, J = 7.9, 7.0 Hz, 2H), 2.46–2.38 (m, 2H), 1.59–1.51 (m, 
2H), 1.34–1.25 (m, 2H), 0.88 (t, J = 7.3 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d): δ 208.2, 168.1, 134.0, 132.0, 123.2, 42.6, 40.5, 33.0, 
25.7, 22.3, 13.8. 
 
HRMS (EI): calcd for C15H17O3N (M
 +
): 259.1208; found 259.1209. 
 
 
2-(oct-3-en-2-yl)isoindoline-1,3-dione (Scheme 2) 
 
Was obtained in 78% yield (100 mg, 0.39 mmol, 10:1 E/Z) following general procedure 2 on 
a 0.5 mmol scale using 2-butenylphthalimide as the limiting reagent and hexene as the cross-
partner (5 equiv). 
1
H NMR (500 MHz, Chloroform-d, major): δ 7.81 (dd, J = 5.4, 3.0 Hz, 2H), 7.69 (dd, J = 5.5, 
3.0 Hz, 2H), 5.87 (ddt, J = 15.4, 7.6, 1.5 Hz, 1H), 5.67 (dtd, J = 15.4, 6.7, 1.1 Hz, 1H), 4.93–
4.84 (m, 1H), 2.06–1.97 (m, 2H), 1.55 (d, J = 7.1 Hz, 3H), 1.36–1.25 (m, 4H), 0.87 (t, J = 
7.4, 3H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 168.0, 133.8, 133.3, 132.1, 128.4, 123.0, 48.9, 
31.8, 31.1, 22.2, 19.0, 13.9. 
 
HRMS (EI): calcd for C16H19O2N (M
 +
): 257.1416; found 257.1415. 
 
 
2-(4-oxooctan-2-yl)isoindoline-1,3-dione (Scheme 2) 
 Was obtained in 75% yield (30.6 mg, 0.11 mmol) following general procedure 1 on a 0.15 
mmol scale. A single isomer was observed by crude NMR-analysis, accompanied by a small 
impurity that was not assigned to the minor regioisomer. 
1
H NMR (500 MHz, Chloroform-d, major): δ 7.80 (dd, J = 5.4, 3.1 Hz, 2H), 7.69 (dd, J = 5.5, 
3.0 Hz, 2H), 4.90–4.78 (m, 1H), 3.27 (dd, J = 17.6, 8.1 Hz, 1H), 2.96 (dd, J = 17.6, 6.4 Hz, 
1H), 2.39 (td, J = 7.5, 3.7 Hz, 2H), 1.54–1.47 (m, 2H), 1.43 (d, J = 6.9 Hz, 3H), 1.30–1.22 
(m, 2H), 0.85 (t, J = 7.3 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 208.3, 168.2, 133.8, 131.9, 123.1, 45.7, 42.8, 
42.5, 25.7, 22.2, 18.9, 13.8. 
 
HRMS (EI): calcd for C16H19O3N (M
 +
): 273.1365; found 273.1366. 
 
(Z)-undec-2-enyl benzoate (Scheme 3) 
 
Was obtained in 71% yield (78 mg, 0.29 mmol, > 95% Z) following general procedure 3 at 35 
°C on a 0.4 mmol scale using allyl benzoate as the limiting reagent. 
1
H NMR (500 MHz, Chloroform-d): δ 8.05 (dd, J = 7.9, 1.7 Hz, 2H), 7.59 – 7.52 (m, 1H), 
7.44 (t, J = 7.6 Hz, 2H), 5.69 (tq, J = 11.2, 6.1, 5.1 Hz, 2H), 4.87 (d, J = 6.2 Hz, 2H), 2.17 (q, 
J = 7.1 Hz, 2H), 1.39 (q, J = 7.3 Hz, 2H), 1.35–1.18 (m, 10H), 0.87 (t, J = 6.7 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d): δ 166.6, 135.8, 132.9, 130.3, 129.6, 128.3, 123.2, 60.9, 
31.9, 29.4, 29.4, 29.3, 29.2, 27.6, 22.7, 14.1. 
 
HRMS (FAB): calcd for C18H27O2 (M
+
 +H): 275.2011; found 275.2007. 
3-oxoundecyl benzoate (Scheme 3) 
 
Was obtained in 71% yield (41 mg, 0.14 mmol) following general procedure 1 on a 0.2 mmol 
scale. 
1
H NMR (500 MHz, Chloroform-d, major): δ 7.99 (dd, J = 8.4, 1.4 Hz, 2H), 7.57–7.52 (m, 
1H), 7.45–7.39 (m, 2H), 4.59 (t, J = 6.3 Hz, 2H), 2.87 (t, J = 6.3 Hz, 2H), 2.46 (t, J = 7.4 Hz, 
2H), 1.59 (m, 2H), 1.31–1.22 (m, 10H), 0.87 (t, J = 6.9 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 208.1, 166.4, 133.0, 129.6, 128.3, 128.3, 60.0, 
43.3, 41.4, 31.8, 29.3, 29.2, 29.1, 23.7, 22.6, 14.1. 
 
HRMS (FAB): calcd for C18H27O3 (M
+
 +H): 291.1960; found 291.1956. 
(Z)-2-(undec-2-enyl)isoindoline-1,3-dione (Scheme 3) 
 
Was obtained in 62% yield (74 mg, 0.25 mmol, >95% Z) following general procedure 3 at 
RT on a 0.4 mmol scale using allyl phthalimide as the limiting reagent. 
1
H NMR (500 MHz, Chloroform-d, major): δ 7.84 (dd, J = 5.4, 3.1 Hz, 2H), 7.70 (dd, J = 5.5, 
3.0 Hz, 2H), 5.59 (dtt, J = 10.4, 7.4, 1.4 Hz, 1H), 5.50–5.42 (m, 1H), 4.31 (ddt, J = 7.0, 1.4, 
0.6 Hz, 2H), 2.25 (qd, J = 7.4, 1.6 Hz, 2H), 1.44–1.36 (m, 2H), 1.36–1.21 (m, 10H), 0.91–
0.85 (m, 3H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 168.0, 134.7, 133.9, 132.2, 123.2, 122.7, 34.9, 
31.9, 29.5, 29.4, 29.3, 29.3, 27.4, 22.7, 14.1. 
 HRMS (EI): calcd for C19H25O2N (M
 +
): 299.1885; found 299.1890. 
 
2-(3-oxoundecyl)isoindoline-1,3-dione (Scheme 3) 
 
Was obtained in 79% yield (25 mg, 0.08 mmol) following general procedure 3 on a 0.1 mmol 
scale. 
1
H NMR (500 MHz, Chloroform-d): δ 7.83 (dd, J = 5.4, 3.0 Hz, 2H), 7.71 (dd, J = 5.5, 3.0 
Hz, 2H), 3.97–3.93 (m, 2H), 2.84 (dd, J = 7.9, 7.0 Hz, 2H), 2.42 (t, J = 7.5 Hz, 2H), 1.60–
1.50 (m, 2H), 1.31–1.20 (m, 10H), 0.89–0.84 (m, 3H). 
 
13
C NMR (125 MHz, Chloroform-d): δ 208.3, 168.1, 134.0, 132.0, 123.3, 42.9, 40.5, 33.0, 
31.8, 29.3, 29.2, 29.1, 23.6, 22.6, 14.1. 
 
HRMS (EI): calcd for C19H25O3N (M
 +
): 315.1834; found 315.1822. 
 
8-(4-hydroxy-3-methoxybenzylamino)-8-oxooct-2-enyl benzoate (Scheme 4) 
 
Was obtained in 64% yield (84 mg, 0.21 mmol, E/Z 6:1) following general procedure 2 on a 
0.33 mmol scale using capsaicin as limiting reagent and cis-dibenzoylbutenol (5 equiv) as 
cross-partner. 
1
H NMR (500 MHz, Chloroform-d, major): δ 8.07–8.02 (m, 2H), 7.59–7.52 (m, 1H), 7.46–
7.39 (m, 2H), 6.86 (d, J = 8.0 Hz, 1H), 6.81–6.74 (m, 2H), 5.86–5.79 (m, 1H), 5.73–5.61 (m, 
3H), 4.75 (dq, J = 6.3, 1.0 Hz, 2H), 4.35 (d, J = 5.6 Hz, 2H), 3.86 (s, 3H), 2.21 (t, J = 7.6 Hz, 
2H), 2.14–2.07 (m, 2H), 1.75–1.58 (m, 2H), 1.45 (tdd, J = 9.9, 7.2, 5.6 Hz, 2H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 172.6, 166.4, 146.7, 145.1, 135.8, 132.9, 
130.3, 130.3, 129.6, 128.3, 124.3, 120.8, 114.3, 110.7, 65.6, 55.9, 43.5, 36.6, 32.0, 28.4, 25.2. 
 
HRMS (FAB): calcd for C23H28O5N (M
 +
): 398.1967; found 398.1966. 
 
8-(4-hydroxy-3-methoxybenzylamino)-3,8-dioxooctyl benzoate (Scheme 4) 
 
Was obtained in 78% yield (32 mg, 0.08 mmol, 20:1 mixture of isomers) following general 
procedure 1 on a 0.1 mmol scale. 
1
H NMR (500 MHz, Chloroform-d, major): δ 8.01–7.95 (m, 2H), 7.54 (ddt, J = 7.9, 7.0, 1.3 
Hz, 1H), 7.45–7.38 (m, 2H), 6.85 (d, J = 8.0 Hz, 1H), 6.79 (d, J = 1.9 Hz, 1H), 6.75 (dd, J = 
8.1, 2.0 Hz, 1H), 5.86 (t, J = 5.5 Hz, 1H), 5.70 (s, 1H), 4.57 (t, J = 6.3 Hz, 2H), 4.33 (d, J = 
5.6 Hz, 2H), 3.86 (s, 3H), 2.85 (t, J = 6.3 Hz, 2H), 2.51 (t, J = 6.6 Hz, 2H), 2.27–2.16 (m, 
2H), 1.65 (m, 4H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 207.6, 172.3, 166.4, 146.7, 145.1, 133.1, 
130.2, 129.9, 129.5, 128.4, 120.8, 114.4, 110.7, 59.9, 55.9, 43.6, 42.8, 41.5, 36.4, 25.0, 23.0. 
 
HRMS (FAB): calcd for C23H28O6N (M
 +
): 414.1917; found 414.1928. 
 
(E)-undec-2-enyl benzoate (A) and (E)-11-hydroxyundec-2-enyl benzoate (B) (Scheme 4) 
 A and B were obtained in 62% yield (170 mg, 0.62 mmol, E/Z 7:1, A) and 63% yield (182 
mg, 0.63 mmol, E/Z 8:1, B) following general procedure 2 on a 1 mmol scale using oleyl 
alcohol as limiting reagent and cis-dibenzoylbutenol (5 equiv) as cross-partner. 
A: see below 
 
B: 
1
H NMR (500 MHz, Chloroform-d, major): δ 8.09–8.02 (m, 2H), 7.58–7.53 (m, 1H), 
7.46–7.41 (m, 2H), 5.91–5.80 (m, 1H), 5.73–5.63 (m, 1H), 4.77 (dq, J = 6.4, 1.0 Hz, 2H), 
3.64 (t, J = 6.6 Hz, 2H), 2.11–2.05 (m, 2H), 1.61–1.25 (m, 13H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 166.5, 136.6, 132.9, 130.4, 129.6, 128.3, 
123.8, 65.8, 63.1, 32.8, 32.3, 29.4, 29.3, 29.1, 28.8, 25.7. 
 
HRMS (FAB): calcd for C18H27O3 (M
 + 
+ H): 291.1960; found 291.1965. 
 
3-oxoundecyl benzoate (Scheme 4) 
 
Was obtained in 78% yield (45 mg, 0.16 mmol) following general procedure 1 on a 0.2 mmol 
scale. Isomeric ratio was 20:1 by NMR-analysis of the crude. 
1
H NMR (500 MHz, Chloroform-d): δ 7.99 (dd, J = 8.4, 1.4 Hz, 2H), 7.58–7.52 (m, 1H), 
7.46–7.38 (m, 2H), 4.59 (t, J = 6.3 Hz, 2H), 2.87 (t, J = 6.3 Hz, 2H), 2.46 (t, J = 7.4 Hz, 2H), 
1.60 (t, J = 7.3 Hz, 2H), 1.32 – 1.18 (m, 10H), 0.87 (t, J = 6.9 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d): δ 208.1, 166.4, 133.0, 129.6, 128.3, 128.3, 60.0, 43.3, 
41.4, 31.8, 29.3, 29.2, 29.1, 23.7, 22.6, 14.1. 
 
HRMS (FAB): calcd for C18H27O3 (M
 +
+H): 291.1960; found 291.1956. 
 11-hydroxy-3-oxoundecyl benzoate (Scheme 4) 
 
Was obtained in 77% yield (47 mg, 0.15 mmol, E/Z 6:1) following general procedure 1 on a 
0.2 mmol scale. 
1
H NMR (500 MHz, Chloroform-d): 8.01–7.96 (m, 2H), 7.57–7.52 (m, 1H), 7.44–7.39 (m, 
2H), 4.58 (t, J = 6.3 Hz, 2H), 3.62 (t, J = 6.6 Hz, 2H), 2.86 (t, J = 6.3 Hz, 2H), 2.46 (t, J = 7.4 
Hz, 2H), 1.64–1.49 (m, 3H), 1.36–1.24 (m, 10H). 
 
13
C NMR (125 MHz, Chloroform-d): δ 208.1, 166.4, 133.0, 123.0, 129.6, 128.3, 63.0, 60.0, 
43.2, 41.4, 32.7, 29.3, 29.2, 29.0, 25.6, 23.6. 
 
HRMS (FAB): calcd for C18H27O4 (M
 +
+H): 307.1909; found 307.1919. 
3-oxooctyl 4-nitrobenzoate (Scheme 5) 
 
Was obtained in 76% yield (133 mg, 0.45 mmol) following general procedure 1 on a 0.6 
mmol scale. Isomeric ratio was 28:1 as determined by NMR analysis of the crude reaction 
mixture. 
1
H NMR (500 MHz, Chloroform-d): δ 8.26 (d, J = 8.8 Hz, 2H), 8.15 (d, J = 8.9 Hz, 2H), 4.63 
(t, J = 6.2 Hz, 2H), 2.90 (t, J = 6.2 Hz, 2H), 2.47 (t, J = 7.4 Hz, 2H), 1.65–1.54 (m, 2H), 
1.35–1.20 (m, 4H), 0.87 (t, J = 7.0 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d): δ 207.6, 164.5, 150.5, 135.3, 130.7, 123.5, 60.7, 43.2, 
41.1, 31.3, 23.3, 22.4, 13.9. 
 
HRMS (EI): calcd for C15H20O5N (M
 +
+H): 294.1341; found 294.1352. 
3-oxooctyl 4-methoxybenzoate (Scheme 5) 
 
Was obtained in 74% yield (124 mg, 0.45 mmol) following general procedure 1 on a 0.6 
mmol scale.  Isomeric ratio was 16:1 as determined by NMR analysis of the crude reaction 
mixture. 
 
1
H NMR (500 MHz, Chloroform-d, major): δ 7.94 (d, J = 8.9 Hz, 2H), 6.89 (d, J = 8.9 Hz, 
1H), 4.55 (t, J = 6.4 Hz, 2H), 3.84 (s, 3H), 2.85 (t, J = 6.4 Hz, 2H), 2.45 (t, J = 7.4 Hz, 2H), 
1.59 (tt, J = 8.0, 7.1 Hz, 2H), 1.36–1.20 (m, 5H), 0.87 (t, J = 7.1 Hz, 3H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 208.3, 166.1, 163.4, 131.6, 122.4, 113.6, 59.7, 
55.4, 43.3, 41.5, 31.3, 23.3, 22.4, 13.9. 
 
HRMS (EI): calcd for C16H22O4 (M
 +
): 278.1518; found 278.1509. 
Intermolecular Competition experiments (Scheme 5) 
Three competition experiments were run using 5 mol% catalyst and only 10 mol% 
benzoquinone to enable only low conversions to be achieved. A 1:1 ratio of competing 
substrates was used, and after two hours the ratio of products was determined by analysis of 
the proton NMR. Results: 
MeO vs H:   1.2 to 1 
NO2 vs H:   0.5 to 1 
MeO vs NO2:   2.4 to 1 
OBz vs OBn  1 to 3.5 
OBn vs CH2OBz 1 to 2.2 (therefore CH2OBz is 2.2*3.5 = 7.7 faster than OBz) 
Intermolecular Competition experiments (Scheme 5) 
 
Was obtained in 50% yield (34.3 mg, 0.1 mmol) following general procedure 1 on a 0.2 
mmol scale.  Isomeric ratio was 31:1 as determined by NMR analysis of the crude reaction 
mixture. Peaks for the minor and major isomer were assigned by comparison of the triplet 
shifts in the H-NMR with the compounds made above and matched their values (major, 
triplet next to 4-NO2BzO: 4.62; minor, triplet next to OBn: 3.77)  
1
H NMR (500 MHz, Chloroform-d, major): δ 8.26 (d, J = 9.0 Hz, 2H), 8.15 (d, J = 9.0 Hz, 
2H), 7.39 – 7.32 (m, 5H), 4.66 (t, J = 6.2 Hz, 2H), 4.61 (s, 2H), 4.11 (s, 2H), 3.02 (t, J = 6.2 
Hz, 2H). 
 
13
C NMR (125 MHz, Chloroform-d, major): δ 205.8, 164.5, 150.6, 136.8, 135.3, 130.7, 
128.6, 128.2, 127.9, 123.8, 75.2, 73.5, 60.3, 38.0. 
 
HRMS (EI): calcd for C18H18NO6 (M
 
+H
+
): 344.1134; found 344.1121. 
 
 
  
  
 
 
   
  
  
 
  
  
 
 
  
  
 
  
  
 
  
  
 
  
  
 
  
  
 
  
  
 
 
  
 
  
 
  
 
 
 
  
 
 
 
  
 
 
 
 
